(Q38952569)

English

Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response

scientific article published on 29 September 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

author name string

N Erin

1

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

A Podnos

2

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

G Tanriover

3

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Ö Duymuş

4

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

E Cote

5

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

I Khatri

6

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

R M Gorczynski

7

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

language of work or name

0 references

publication date

29 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

3860-3870

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

CD200 is a ligand for all members of the CD200R family of immunoregulatory molecules

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Characterization of the CD200 receptor family in mice and humans and their interactions with CD200.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Mice lacking CD200R1 show absence of suppression of lipopolysaccharide-induced tumor necrosis factor-alpha and mixed leukocyte culture responses by CD200.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Upregulation of CD200 is associated with Foxp3+ regulatory T cell expansion and disease progression in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

CD200-CD200R signaling suppresses anti-tumor responses independently of CD200 expression on the tumor

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

The immunosuppressive surface ligand CD200 augments the metastatic capacity of squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

CD200-expressing human basal cell carcinoma cells initiate tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Melanoma cell expression of CD200 inhibits tumor formation and lung metastasis via inhibition of myeloid cell functions

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Increased expression of P-glycoprotein is associated with doxorubicin chemoresistance in the metastatic 4T1 breast cancer model

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Vagotomy enhances experimental metastases of 4THMpc breast cancer cells and alters substance P level

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Capsaicin-induced inactivation of sensory neurons promotes a more aggressive gene expression phenotype in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Altered gene expression in breast cancer liver metastases

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Differential characteristics of heart, liver, and brain metastatic subsets of murine breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Role of CD200 expression in regulation of metastasis of EMT6 tumor cells in mice

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Down-regulation of the macrophage lineage through interaction with OX2 (CD200)

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Interleukin-6 inhibits regulatory T cells and improves the proliferation and cytotoxic activity of cytokine-induced killer cells.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Cytokine patterns in patients with cancer: a systematic review.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Phenotypic switch in blood: effects of pro-inflammatory cytokines on breast cancer cell aggregation and adhesion

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Suppression of lymphoma and epithelial malignancies effected by interferon gamma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Primary antitumor immune response mediated by CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Interleukin-10: new perspectives on an old cytokine

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Tumour-infiltrating CD8+ lymphocytes as an independent predictive factor for pathological complete response to primary systemic therapy in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Tumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Breast cancer cell CD200 expression regulates immune response to EMT6 tumor cells in mice

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Cure of metastatic growth of EMT6 tumor cells in mice following manipulation of CD200:CD200R signaling

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Immunoediting of cancers may lead to epithelial to mesenchymal transition.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Which came first, tumor cells or macrophages?

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Identification of S100A8 and S100A9 as serological markers for colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Primary tumours modulate innate immune signalling to create pre-metastatic vascular hyperpermeability foci.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Premetastatic soil and prevention of breast cancer brain metastasis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Expression of a CD200 transgene is necessary for induction but not maintenance of tolerance to cardiac and skin allografts.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

21 January 2018

Evidence of a role for CD200 in regulation of immune rejection of leukaemic tumour cells in C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

31 March 2020

Blockade of CD200 in the presence or absence of antibody effector function: implications for anti-CD200 therapy

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

31 March 2020

Soluble CD200 is critical to engraft chronic lymphocytic leukemia cells in immunocompromised mice

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

31 March 2020

Further evidence for a role of tumor CD200 expression in breast cancer metastasis: decreased metastasis in CD200R1KO mice or using CD200-silenced EMT6

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

31 March 2020

The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential?

1 reference

https://api.crossref.org/works/10.1038%2FONC.2014.317

31 March 2020

CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/25263452

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Capsaicin-mediated denervation of sensory neurons promotes mammary tumor metastasis to lung and heart

1 reference

https://pubmed.ncbi.nlm.nih.gov/25263452

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/ONC.2014.317

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38952569&oldid=2202362511"